Loading this company
Globe Life Inc.
GLPrices in USD
TickerWorth ScoreB57/100
What we think
Bank model: about $314.85 (range $259.42 to $400.39). Justified price-to-book, not a DCF.
Price
$169.72USD up +$1.87 (+1.11%)
Quoted · Prices are delayed.
Why did it move today?
Nothing we can cite explains today’s move for this company.
What our bank model says
Bank-model estimate
$314.85
Range $259.42 to $400.39, for a cost of equity ±1% (6.2%–8.2%)
Price $169.72Priced · Prices are delayed.
Justified price-to-book, not a DCF. One formula’s estimate, not a price target.
Is it a good business?
- Valuation100 out of 100
- Growth83 out of 100
- Financial health33 out of 100
- Dividend75 out of 100
- Past performance100 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
$193.18 across 11 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. It operates in the Insurance - Life industry (Financial Services sector), headquartered in United States. The company employs roughly 3,695 people.
Key stats
52-week range$127.85–$191.55
- Open
- $166.09
- Day high
- $170.11
- Day low
- $166.44
- Previous close
- $167.85
- Volume
- 442,112 · 0.86× avg
- Average volume
- 515,618
- Market cap
- $13,042,888,704.00
- P/E (TTM)
- 11.26
- Earnings per share
- $15.07
- Beta
- 0.44
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
- Changed leadership or its board
- Reported quarterly or annual results
- Signed a material agreement
- Changed leadership or its board
- Reported quarterly or annual results
- Changed leadership or its board
- Reported quarterly or annual results
Top news
No recent headlines we can cite for this company.
Insider trades
The 90-day buying-and-selling read is part of Pro. See plans
- Hensley Robert EdwardOption exercise · $1,032,300.00
- Hensley Robert EdwardOpen-market sale ·
Not investment advice. TickerWorth Score is a model output.